Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia

Published:2016-04-11 Issue:22 Volume:7 Page:32532-32542
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Vey Norbert¹²,Delaunay Jacques³,Martinelli Giovanni⁴,Fiedler Walter⁵,Raffoux Emmanuel⁶,Prebet Thomas¹,Gomez-Roca Carlos⁷⁸,Papayannidis Cristina⁴,Kebenko Maxim⁵,Paschka Peter⁹,Christen Randolph¹⁰,Guarin Ernesto¹¹,Bröske Ann-Marie¹²,Baehner Monika¹²,Brewster Michael¹³,Walz Antje-Christine¹¹,Michielin Francesca¹¹,Runza Valeria¹²,Meresse Valerie¹¹,Recher Christian⁷¹⁴

Affiliation:

1. Institut Paoli-Calmettes, Marseille, France

2. Aix Marseille Université, Marseille, France

3. Service d'Hématologie Clinique, Hôpital Hôtel-Dieu, Nantes, France

4. Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy

5. Department of Medicine II, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

6. Hôpital Saint Louis, AP-HP, EA3518 Université Paris VII, Paris, France

7. Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France

8. Institut Claudius Regaud, Clinical Research Unit, Toulouse, France

9. Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany

10. Product Development, Safety Risk Management, Roche, Basel, Switzerland

11. Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland

12. Pharma Research & Early Development, Roche Innovation Center Penzberg, Penzberg, Germany

13. Pharma Research & Early Development, Roche Innovation Centre, Welwyn, UK

14. CHU de Toulouse, Université Toulouse III, Toulouse, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas;International Journal of Molecular Sciences;2024-08-24

2. Cancer stem cells: advances in knowledge and implications for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-05

3. Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells;Cell Biochemistry and Function;2024-06

4. Natural killer cells associate with epithelial cells in the pancreatic ductal adenocarcinoma tumor microenvironment;2024-05-28

5. CD44: a cancer stem cell marker and therapeutic target in leukemia treatment;Frontiers in Immunology;2024-04-26